Exploring the Endothelin-1 pathway in chronic thromboembolic pulmonary hypertension microvasculopath...
Exploring the Endothelin-1 pathway in chronic thromboembolic pulmonary hypertension microvasculopathy
About this item
Full title
Author / Creator
Feriel, Benchenouf , Alessandra, Cuomo , Deborah, Gorth J. , Corinne, Normand , Raphaël, Thuillet , Mina, Ottaviani , Ali, Akamkam , Jean-Baptiste, Menager , Guillaume, Fadel , Julien, Grynblat , Maria-Rosa, Ghigna , Elie, Fadel , Laurent, Savale , Olaf, Mercier , Ly, Tu , Marc, Humbert and Christophe, Guignabert
Publisher
London: Nature Publishing Group UK
Journal title
Language
English
Formats
Publication information
Publisher
London: Nature Publishing Group UK
Subjects
More information
Scope and Contents
Contents
Targeted vasopeptide therapies have significantly advanced the management of pulmonary arterial hypertension (PAH). However, due to insufficient preclinical evidence regarding the involvement of the endothelin-1 (ET-1) pathway in chronic thromboembolic pulmonary hypertension (CTEPH) pathophysiology, the potential of ET-1 receptor antagonism in trea...
Alternative Titles
Full title
Exploring the Endothelin-1 pathway in chronic thromboembolic pulmonary hypertension microvasculopathy
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_692b8624e8f24a5bafb0489c5106e6e7
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_692b8624e8f24a5bafb0489c5106e6e7
Other Identifiers
ISSN
2045-2322
E-ISSN
2045-2322
DOI
10.1038/s41598-024-79623-5
